- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
D. Kyle Sampson
Insight 11 results
Client Alert
October 31, 2019
USDA Issues Interim Final Rule to Establish Domestic Hemp Production Program and Approve State and Tribal Oversight Plans
Client Alert
August 6, 2019
A Gimmick No More? HHS Moves to Authorize Prescription Drug Importation
Article · Source: Intellectual Property & Technology Law Journal
July 1, 2019
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Client Alert
April 9, 2019
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Client Alert
April 8, 2019
FDA Regulation of Cannabis
Client Alert
January 22, 2019
FDA Tackles Digital Health Software Devices with New Pre-Certification Review Plan
Client Alert
August 17, 2018
FDA Releases Draft Guidance on Agency Decisions Not to Issue Certificates to Foreign Governments
Client Alert
June 25, 2018
FDA Classifies Next Generation Sequencing-Based Tumor Profiling In Vitro Diagnostic Into Class II (Special Controls)
Client Alert
December 14, 2017
FDA Releases Long-Awaited Guidances on the Regulation of Digital Health Tools
Client Alert
June 13, 2017
The Age of Competition
Client Alert
January 19, 2017
FDA Issues Discussion Paper on LDTs